Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com
TORONTO, Jan. 12, 2018 /PRNewswire/ — Alternate Health Corp. (“Alternate Health” or the “Company”) (CSE: AHG) (OTC: AHGIF), an international medical cannabis company that uses technology, research, and clinical services to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices, today announced that Dr. Michael Murphy, CEO, will present live at VirtualInvestorConferences.com on January 18, 2018.
DATE: Thursday January 18, 2018
TIME: 12:30 PM EST
This will be a live, interactive online event where investors are invited to ask the company questions in real-time – both in the presentation hall as well as the association’s “virtual trade booth.” If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
Receipt of Medicare license approval for Alternate Health Labs Installation of CanaPass software platform is progressing well in National Access Cannabis’ 11 Canadian clinics serving 12,000 clients. CanaPass Florida-specific adaption FlorPass has launched in Florida clinics making inroads into other states with additional adaptations. Negotiated the acquisition of a Blockchain-Enabled Mobile Payment software application completed in November, adding mobile payment solutions and point of sale capabilities. Alternate Health Lab conversion to a full clinical lab is expected to continue generating long-term stable revenues.
About Alternate Health Corp.
Alternate Health Corp. (CSE: AHG, OTCQB: AHGIF) Alternate Health has established multiple arms-length operations within the medical cannabis industry, each of which drives consumers, data and strategic opportunities to the company’s other verticals. This sophisticated cross-integration of the company’s enterprises has positioned Alternate Health as one of the only cannabis companies that delivers consistent revenue and intellectual property without growing, manufacturing or distributing the cannabis plant. Through its software solutions, data analytics, and patented delivery systems, Alternate Health’s goal is to be the global authority on scientific and clinical support for cannabis in regulated markets. Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders.